HomeREGULATORY
REGULATORY

3 Pharma Groups Push for Price Maintenance during Patent Term: Chuikyo Hearing
(May.17.2017)

FPMAJ Chairman Masayo Tada (left), JPMA President Yoshihiko Hatanaka
Three major pharma trade groups of Japan, the US, and Europe all pressed for a scheme to keep NHI drug prices for the duration of the patent term at a hearing of a key drug pricing panel on May 17 - aiming to turn the tide amid a growing headwind for the so-called price maintenance premium ...
(LOG IN FOR FULL STORY)

News Calendar